L

Liver Associates of Texas, P.A. | Fannin Office

Research site
(Unclaimed)
Location
University of Texas Professional Building, 6410 Fannin Street, Suite 225, Houston, Texas, United States of America
Site insights

Top conditions

Fatty Liver (7 trials)

Non-alcoholic Fatty Liver Disease (7 trials)

Fibrosis (4 trials)

Cholangitis (3 trials)

Biliary Liver Cirrhosis (2 trials)

Top treatments

Obeticholic Acid
Emricasan
Elafibranor
Selonsertib
OCA
Cilofexor
Firsocostat

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)

The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid...

Active, not recruiting
Primary Biliary Cirrhosis
Drug: Elafibranor 80mg
Drug: Placebo

The goals of this clinical study are to learn more about the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firso...

Active, not recruiting
Nonalcoholic Steatohepatitis
Drug: PTM CILO/FIR
Drug: Cilofexor (CILO)/Firsocostat (FIR)

Trial sponsors

I

Intercept Pharmaceuticals (3 trials)

Gilead Sciences logo

Gilead Sciences (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems